ID HDNO_ARTOX Reviewed; 458 AA. AC P08159; DT 01-AUG-1988, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-1991, sequence version 2. DT 16-JUN-2009, entry version 60. DE RecName: Full=6-hydroxy-D-nicotine oxidase; DE Short=6-HDNO; DE EC=1.5.3.6; OS Arthrobacter oxidans. OC Bacteria; Actinobacteria; Actinobacteridae; Actinomycetales; OC Micrococcineae; Micrococcaceae; Arthrobacter. OX NCBI_TaxID=1671; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX MEDLINE=87304263; PubMed=3622516; RX DOI=10.1111/j.1432-1033.1987.tb13338.x; RA Brandsch R., Hinkkanen A.E., Mauch L., Nagursky H., Decker K.; RT "6-hydroxy-D-nicotine oxidase of Arthrobacter oxidans. Gene structure RT of the flavoenzyme and its relationship to 6-hydroxy-L-nicotine RT oxidase."; RL Eur. J. Biochem. 167:315-320(1987). RN [2] RP SEQUENCE REVISION. RA Brandsch R.; RL Submitted (SEP-1990) to the EMBL/GenBank/DDBJ databases. RN [3] RP FLAVIN BINDING AT HIS-71, AND MUTAGENESIS OF HIS-71. RX MEDLINE=90033359; PubMed=2680607; DOI=10.1016/0014-5793(89)81792-2; RA Mauch L., Bichler V., Brandsch R.; RT "Site-directed mutagenesis of the FAD-binding histidine of 6-hydroxy- RT D-nicotine oxidase. Consequences on flavinylation and enzyme RT activity."; RL FEBS Lett. 257:86-88(1989). RN [4] RP MUTAGENESIS OF ARG-67 AND SER-68. RX MEDLINE=90330600; PubMed=2115879; RA Mauch L., Bichler V., Brandsch R.; RT "Lysine can replace arginine 67 in the mediation of covalent RT attachment of FAD to histidine 71 of 6-hydroxy-D-nicotine oxidase."; RL J. Biol. Chem. 265:12761-12762(1990). CC -!- CATALYTIC ACTIVITY: (R)-6-hydroxynicotine + H(2)O + O(2) = 1-(6- CC hydroxypyridin-3-yl)-4-(methylamino)butan-1-one + H(2)O(2). CC -!- COFACTOR: FAD. CC -!- PATHWAY: Alkaloid degradation; nicotine degradation. CC -!- SIMILARITY: Belongs to the oxygen-dependent FAD-linked CC oxidoreductase family. CC -!- SIMILARITY: Contains 1 FAD-binding PCMH-type domain. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; X05999; CAA29416.1; -; Genomic_DNA. DR PIR; S00087; DEIQHN. DR SMR; P08159; 4-456. DR GO; GO:0018530; F:(R)-6-hydroxynicotine oxidase activity; IEA:EC. DR GO; GO:0009055; F:electron carrier activity; IEA:InterPro. DR GO; GO:0050660; F:FAD binding; IEA:InterPro. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR InterPro; IPR012951; BBE. DR InterPro; IPR016166; FAD-bd_2. DR InterPro; IPR006094; Oxid_FAD_bind_N. DR InterPro; IPR006093; Oxy_OxRdtase_FAD_BS. DR Pfam; PF08031; BBE; 1. DR Pfam; PF01565; FAD_binding_4; 1. DR PROSITE; PS51387; FAD_PCMH; 1. DR PROSITE; PS00862; OX2_COVAL_FAD; 1. PE 1: Evidence at protein level; KW FAD; Flavoprotein; Oxidoreductase. FT CHAIN 1 458 6-hydroxy-D-nicotine oxidase. FT /FTId=PRO_0000128157. FT DOMAIN 33 204 FAD-binding PCMH-type. FT MOD_RES 71 71 Tele-8alpha-FAD histidine. FT MUTAGEN 67 67 R->A: No FAD incorporation. FT MUTAGEN 67 67 R->K: No effect on FAD incorporation, but FT reduces activity. FT MUTAGEN 68 68 S->A: No effect on FAD incorporation or FT on activity. FT MUTAGEN 71 71 H->C,Y,S: No FAD incorporation, abolishes FT or diminishes significantly the activity. SQ SEQUENCE 458 AA; 48786 MW; 6783E444D66DC841 CRC64; MSSKLATPLS IQGEVIYPDD SGFDAIANIW DGRHLQRPSL IARCLSAGDV AKSVRYACDN GLEISVRSGG HNPNGYATND GGIVLDLRLM NSIHIDTAGS RARIGGGVIS GDLVKEAAKF GLAAVTGMHP KVGFCGLALN GGVGFLTPKY GLASDNILGA TLVTATGDVI YCSDDERPEL FWAVRGAGPN FGVVTEVEVQ LYELPRKMLA GFITWAPSVS ELAGLLTSLL DALNEMADHI YPSVFVGVDE NRAPSVTVCV GHLGGLDIAE RDIARLRGLG RTVSDSIAVR SYDEVVALNA EVGSFEDGMS NLWIDREIAM PNARFAEAIA GNLDKFVSEP ASGGSVKLEI EGMPFGNPKR TPARHRDAMG VLALAEWSGA APGSEKYPEL ARELDAALLR AGVTTSGFGL LNNNSEVTAE MVAEVYKPEV YCRLAAVKRE YDPENRFRHN YNIDPEGS //